Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 9Head & Neck 9Dermatologic 7Breast 4Lymphoid 3CNS 3Myeloid 2Genitourinary 2Gastrointestinal 2Other hematologic neoplasm 1Gynecologic 1

Conditions

Ovarian Neoplasms 2565Uterine Cervical Neoplasms 1684Endometrial Neoplasms 1008Fallopian Tube Neoplasms 729Carcinoma, Ovarian Epithelial 680Breast Neoplasms 673Neoplasms 436Carcinoma, Non-Small-Cell Lung 377Colorectal Neoplasms 370Pancreatic Neoplasms 302Stomach Neoplasms 301Uterine Cervical Dysplasia 273Prostatic Neoplasms 261Lung Neoplasms 250Melanoma 247Neoplasm Metastasis 214Peritoneal Neoplasms 197Carcinoma, Renal Cell 192Sarcoma 189Head and Neck Neoplasms 188Urinary Bladder Neoplasms 187Esophageal Neoplasms 186Recurrence 184Triple Negative Breast Neoplasms 179Uterine Neoplasms 176Vulvar Neoplasms 173Squamous Cell Carcinoma of Head and Neck 166Colonic Neoplasms 162Papillomavirus Infections 152Small Cell Lung Carcinoma 126

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Soft Tissue Neoplasms × Gynecologic × Clear all
NCT03159585 2020-01-22

To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors

Zhujiang Hospital

Phase 1 Completed
6 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & Neck

Urinary Bladder Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Soft Tissue Neoplasms, Stomach Neoplasms, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡